Analysis of epristeride demonstrates its metabolic profile in zebrafish, suggesting implications for anti-doping efforts.
Epristeride, a novel non-competitive inhibitor of type II 5α-reductase, was studied for its metabolic profile in zebrafish using LC-HRMS, revealing key metabolites in sports medicine and anti-doping efforts.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: